Becker muscular dystrophy (BMD) is an X‐linked neuromuscular disorder due to mutation in
the DMD gene, encoding dystrophin. Despite a wide clinical variability, BMD is …

Our objective was to investigate the potential of three microRNAs, miR-181a-5p, miR-30c-
5p, and miR-206 as prognostic biomarkers for long-term follow up of Duchenne muscular …

Noninvasive biomarkers with diagnostic value and prognostic applications have long been
desired to replace muscle biopsy for Duchenne muscular dystrophy (DMD) patients …

Becker muscular dystrophy (BMD) is an X-linked recessive disorder caused by dystrophin
gene mutations. The phenotype and evolution of this muscle disorder are extremely clinical …

Noncoding RNAs (ncRNAs), such as miRNAs and long noncoding RNAs, are key regulators
of gene expression at the post-transcriptional level and represent promising therapeutic …

Background: Duchenne/Becker muscular dystrophy (DMD/BMD) is an X-linked recessive
lethal neuromuscular disease. MicroRNAs expressed in striated muscle, myomiRs, have …

The amount and distribution of dystrophin protein in myofibers and muscle is highly variable
in Becker muscular dystrophy and in exon-skipping trials for Duchenne muscular dystrophy …

Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD), which
represent the range of dystrophinopathies, account for nearly 80% of muscle dystrophy …

The development of medical approaches requires preclinical and clinical trials for
assessment of therapeutic efficacy. Such evaluation entails the use of biomarkers, which …

Duchenne muscular dystrophy (DMD) is a lethal X-linked disorder caused by mutations in
the dystrophin gene, which encodes a cytoskeletal protein, dystrophin. Creatine kinase (CK) …